Becton, Dickinson Raises 2021 Financial Outlook

By Dave Sebastian

Becton, Dickinson & Co. raised its financial outlook for 2021 after it said it benefited from sales related to Covid-19 testing in the latest quarter, though it said it doesn't see a significant change in procedure volumes associated with Covid-19 resurgences.

The New Jersey-based medical-technology company on Thursday said it sees adjusted earnings of $12.75 a share to $12.85 a share, up from its prior outlook of $12.40 a share to $12.60 a share.

The company expects revenue to grow 12% to 14%, or 10% to 12% on a currency-neutral basis. It previously guided for revenue to rise by high-single to low-double digits. It sees foreign currency contributing about two percentage points to revenue growth, compared with its prior outlook of about one percentage point.

Shares rose 1.9% premarket.

Write to Dave Sebastian at dave.sebastian@wsj.com

(END) Dow Jones Newswires

February 04, 2021 06:36 ET (11:36 GMT)

Becton Dickinson (NYSE:BDX)
Historical Stock Chart
From Aug 2024 to Sep 2024